latapres combi 0,05 mg/ml + 5 mg/ml oldatos szemcsepp
pharmaswiss ceska republika s.r.o - timolol; latanoproszt -
venturax 20 mg/ml+5 mg/ml oldatos szemcsepp
pannonpharma kft. - dorzolamid; timolol -
timdolux 20 mg/ml+5 mg/ml oldatos szemcsepp
pharmaswiss ceska republika s.r.o - dorzolamid; timolol -
kiranol 20 mg/ml+5 mg/ml oldatos szemcsepp
actavis group ptc ehf. - dorzolamid; timolol -
byooviz
samsung bioepis nl b.v. - ranibizumabbal - wet macular degeneration; macular edema; diabetic retinopathy; myopia, degenerative - szemészeti - byooviz is indicated in adults for:the treatment of neovascular (wet) age-related macular degeneration (amd)the treatment of visual impairment due to diabetic macular oedema (dme)the treatment of proliferative diabetic retinopathy (pdr)the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)the treatment of visual impairment due to choroidal neovascularisation (cnv).
ximluci
stada arzneimittel ag - ranibizumabbal - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - szemészeti - ximluci is indicated in adults for:the treatment of neovascular (wet) age-related macular degeneration (amd)the treatment of visual impairment due to diabetic macular oedema (dme)the treatment of proliferative diabetic retinopathy (pdr)the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)the treatment of visual impairment due to choroidal neovascularisation (cnv).
ranivisio
midas pharma gmbh - ranibizumabbal - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - szemészeti - ranivisio is indicated in adults for:• the treatment of neovascular (wet) age-related macular degeneration (amd)• the treatment of visual impairment due to diabetic macular oedema (dme)• the treatment of proliferative diabetic retinopathy (pdr)• the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)• the treatment of visual impairment due to choroidal neovascularisation (cnv).
verorab 2,5 ne/0,5 ml por és oldószer szuszpenziós injekcióhoz ampullában
sanofi pasteur sa - a veszettség vírus, wistar veszettség pm/wi38 1503-3m törzs (inaktivált) -
fluenz
medimmune llc - reassortant influenza vírus (élő, attenuált) bekezdése a következő törzsek:a/california/7/2009 (h1n1)pdm09, mint a törzs, a/victoria/361/2011 (h3n2) - szerű törzs, b/massachusetts/2/2012-szerű törzs - influenza, human; immunization - a vakcinák - az influenza profilaxisa az egyénekben 24 hónapos és 18 év alattiaknál. a használata fluenz kell a hivatalos ajánlásoknak.